FdaApplication
ANDA 215255
Identifiers
- fda_app_no: ANDA215255
Properties
| Property | Value |
|---|---|
| applicant_name | MACLEODS PHARMACEUTICALS LTD |
| application_type | ANDA |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE; CANAGLIFLOZIN | 50MG | TABLET, EXTENDED RELEASE |
| CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE; CANAGLIFLOZIN | 150MG | TABLET, EXTENDED RELEASE |
| CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE; CANAGLIFLOZIN | 1000MG | TABLET, EXTENDED RELEASE |
| CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE; CANAGLIFLOZIN | 500MG | TABLET, EXTENDED RELEASE |
4 products